M
Melissa Bime
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
OCT 19
OCT 26
NOV 2
NOV 9
NOV 16
Oct 19, 2026
START: Melissa Bime, CEO & Founder, Infiuss Health: "AI-Powered clinical rehearsal. Run the trial before you run the trial."
D
4:31DavidHOST
And so now tell us about Infuse Health and building the digital twin to accelerate this pharmaceutical process.
M
4:40Melissa BimeGUEST
So we build digital patient twins that are these computational versions of actual real patients.
M
4:47Melissa BimeGUEST
And the way that we do this is by combining medical records, genetic records, and any sort of unique physiological inputs that patients have.
M
4:56Melissa BimeGUEST
So this could be from wearables that patients have or just by patients responding to a questionnaire that we administer on a monthly basis.
M
5:05Melissa BimeGUEST
And the goal is to be able to accurately as possible represent a real patient and test or sort of rehearse how that real patient will behave in a clinical trial before recruiting the actual patient into the clinical trial.
M
5:22Melissa BimeGUEST
And the reason why this is so important is because You know, when we test a new drug, we really never know how it will react on patients.
D
6:30DavidHOST
What can you do with AI and digital twins today? Like, could you simulate, you know, years of trials on an individual twin?